Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
Price Target
Average
18.21%
Revenue Forecast
Estimate
75.23%
EBIT
Estimate
--23.33%
Net Income
Estimate
45.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Travere Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TVTX of $21.7 , with forecasts ranging from
a
low of
$12 to a high of $33 .
TVTX Lowest Price Target
Wall Street Target
12 USD
-34.68%
TVTX Average Price Target
Wall Street Target
21.7 USD
18.21%
TVTX Highest Price Target
Wall Street Target
33 USD
79.64%
REVENUE FORECAST
Revenue Forecast Chart TVTX
EBIT FORECAST
EBIT Forecast Chart TVTX
NET INCOME FORECAST
Net Income Chart TVTX